Issued Patents All Time
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12144859 | B cell depleting agent for the treatment of atherosclerosis | Hafid Ait-Oufella, Alain Tedgui, Thomas F. Tedder | 2024-11-19 |
| 11752131 | Methods and pharmaceutical compositions for the treatment of obesity | Fatima-Soraya TALEB, Alain Tedgui | 2023-09-12 |
| 9688767 | Method of predicting survival time in myocardial infarction patients by measuring BAFF levels | Alain Tedgui, Tabassome Simon, Nicolas Danchin | 2017-06-27 |
| 9592267 | Use of IL-18BP for treatment of peripheral vascular diseases | Yolande Chvatchko, Alain Tedgui | 2017-03-14 |
| 9573997 | Method for use in the treatment of aneurysm | Soraya Taleb, Alain Tedgui | 2017-02-21 |
| 9566313 | Method of treating peripheral vascular diseases using IL-18 inhibitors | Yolande Chvatchko, Alain Tedgui | 2017-02-14 |
| 8586822 | Methods for producing a non human model for aortic aneurysm | Pierre-Louis Tharaux, Hafid Ait-Oufella, Alain Tedgui | 2013-11-19 |
| 8383355 | Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event | Alain Tedgui, Sotirios Tsimikas, Joseph L. Witztum | 2013-02-26 |
| 8361732 | Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event | Alain Tedgui, Sotirios Tsimikas, Joseph L. Witztum | 2013-01-29 |
| 8324152 | Composition for the treatment of atherosclerosis | Alain Tedgui | 2012-12-04 |
| 8187818 | Use of sPLA2 activity for the diagnosis of a cardiovascular event | Alain Tedgui, Joëlle Benessiano | 2012-05-29 |
| 8163504 | Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event | Alain Tedgui, Sotirios Tsimikas, Joseph L. Witztum | 2012-04-24 |
| 7985409 | Tr1 cells for use in atherosclerosis | Hervé Groux, Alain Tedgui, Valerie Brun | 2011-07-26 |